A Follow-up Study to Evaluate Actinic Keratosis Recurrence Rates One Year After Completion of the 1473-IMIQ Study
Phase 3
18 Years
N/A
18 Years
N/A
Not Enrolling
Both
Keratosis
Both
Keratosis
Trial Information
A Follow-up Study to Evaluate Actinic Keratosis Recurrence Rates One Year After Completion of the 1473-IMIQ Study
Inclusion Criteria:
- Subject had to participate in the 1473-IMIQ Study AND have had 100% clearance of AK
lesions
Exclusion Criteria:
- Did not use any topical preparations in the previous treatment area within 24-hours
of the scheduled visit.
Type of Study:
Observational
Study Design:
Observational Model: Defined Population, Observational Model: Natural History, Time Perspective: Longitudinal, Time Perspective: Prospective
Authority:
United States: Food and Drug Administration
Study ID:
1518-IMIQ
NCT ID:
NCT00114023
Start Date:
January 2005
Completion Date:
Related Keywords:
- Keratosis
- AK
- Imiquimod 5% cream
- 3M Pharmaceuticals
- Aldara
- Actinic Keratosis
- Keratosis
- Keratosis, Actinic
Name | Location |
|---|---|
| Little Rock, Arkansas 72205-7199 |
